Across TCGA pan-cancer cohorts, SELENOV Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated SELENOV data layer compared with 20 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher SELENOV Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated SELENOV expression acts as an unfavorable survival marker.

COAD, SKCM, and ESCA are the cancer types where SELENOV Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	All	0.171	0.694	<.001	13	view →
SKCM	OS	Median	III,IV	0.202	0.705	.006	6	view →
ESCA	DFS	Median	All	0.146	0.533	.046	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: SELENOV tumor-vs-normal RNA expression · all SELENOV data types